| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Articles |
and
Have Opposing Effects on Monocyte Chemotaxis in Endometriosis
Center for Reproductive Sciences (D.H., L.L.W., E.A.R., F.B., R.N.T.), University of California, San Francisco, California 94143; and Department of Obstetrics and Gynecology (D.H., D.W.), Tuebingen 72076, Germany
Address all correspondence and requests for reprints to: Robert N. Taylor, M.D., Ph.D., Center for Reproductive Sciences, HSE 1689, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, California 94143-0556.
Abstract
The peroxisome proliferator-activated receptors (PPARs)
and
are
nuclear receptors that play important roles in inflammatory diseases
like ulcerative colitis and arthritis. In this study, we examined the
possible role of PPARs in macrophage attraction into the peritoneal
cavity of patients with endometriosis. We identified PPAR-
and -
messenger RNA by RT-PCR and protein by immunoblotting of lysates of
peritoneal macrophages and monocytic U937 cells. Using
immunocytochemistry, we localized PPAR-
and -
within the nuclei
of both cell types. Monocyte chemotactic activity of peritoneal fluid
from patients with endometriosis was quantified in Boyden chambers.
Migration of U937 cells was increased by WY 14643 and reduced by
rosiglitazone. Peritoneal fluid from patients with endometriosis
activated U937 cells transiently transfected with a PPAR-
/GAL4
luciferase reporter. By contrast, peritoneal fluid did not cause
significant activation of PPAR-
/GAL4 constructs. The U937 cells
transiently transfected with a PPAR response element luciferase
reporter showed disease stage-dependent up-regulation when treated with
peritoneal fluid from patients with endometriosis. Treatment with
peritoneal fluid from healthy controls down-regulated PPAR response
element transactivation. We conclude that peritoneal fluid of
endometriosis patients contains activators of PPAR-
that stimulate
macrophage chemotaxis. Inhibitors of PPAR-
or activators of PPAR-
could be developed for the treatment of inflammation associated with
endometriosis.
This article has been cited by other articles:
![]() |
A. Aiello, G. Pandini, F. Frasca, E. Conte, A. Murabito, A. Sacco, M. Genua, R. Vigneri, and A. Belfiore Peroxisomal Proliferator-Activated Receptor-{gamma} Agonists Induce Partial Reversion of Epithelial-Mesenchymal Transition in Anaplastic Thyroid Cancer Cells Endocrinology, September 1, 2006; 147(9): 4463 - 4475. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kiyomizu, J. Kitawaki, H. Obayashi, M. Ohta, H. Koshiba, H. Ishihara, and H. Honjo Association of Two Polymorphisms in the Peroxisome Proliferator-Acativated Receptor-{gamma} Gene With Adenomyosis, Endometriosis, and Leiomyomata in Japanese Women Reproductive Sciences, July 1, 2006; 13(5): 372 - 377. [Abstract] [PDF] |
||||
![]() |
L. L. Waite, R. E. Louie, and R. N. Taylor Circulating Activators of Peroxisome Proliferator-Activated Receptors Are Reduced in Preeclamptic Pregnancy J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 620 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Pritts, D. Zhao, E. Ricke, L. Waite, and R. N. Taylor PPAR-{gamma} Decreases Endometrial Stromal Cell Transcription and Translation of RANTES in Vitro J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1841 - 1844. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |